BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 23052161)

  • 1. Neoadjuvant chemo-radiotherapy for locally advanced esophageal cancer: a monocentric study.
    Schena M; La Rovere E; Solerio D; Bustreo S; Barone C; Daniele L; Buffoni L; Bironzo P; Sapino A; Gasparri G; Ciuffreda L; Ricardi U
    Tumori; 2012; 98(4):451-7. PubMed ID: 23052161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective, open, multicentre Phase I/II trial to assess safety and efficacy of neoadjuvant radiochemotherapy with docetaxel and cisplatin for esophageal carcinoma.
    Ma HB; Di ZL; Wen J; Ke Y; Sun X; Ren J
    Jpn J Clin Oncol; 2015 Feb; 45(2):169-75. PubMed ID: 25416813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A retrospective comparison of neoadjuvant chemoradiotherapy regimens for locally advanced esophageal cancer.
    Sanford NN; Catalano PJ; Enzinger PC; King BL; Bueno R; Martin NE; Hong TS; Wo JY; Mamon HJ
    Dis Esophagus; 2017 Jul; 30(7):1-8. PubMed ID: 28475728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant chemoradiation therapy in patients with surgically treated esophageal cancer.
    Vermund H; Pories WJ; Hillard J; Wiley AL; Youngblood R
    Acta Oncol; 2001; 40(5):558-65. PubMed ID: 11669326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant chemoradiotherapy with concurrent cisplatin/5-fluorouracil is associated with increased pathologic complete response and improved survival compared to carboplatin/paclitaxel in patients with locally advanced esophageal cancer.
    Haisley KR; Hart KD; Nabavizadeh N; Bensch KG; Vaccaro GM; Thomas CR; Schipper PH; Hunter JG; Dolan JP
    Dis Esophagus; 2017 Jul; 30(7):1-7. PubMed ID: 28475724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I evaluation of TNFerade biologic plus chemoradiotherapy before esophagectomy for locally advanced resectable esophageal cancer.
    Chang KJ; Reid T; Senzer N; Swisher S; Pinto H; Hanna N; Chak A; Soetikno R
    Gastrointest Endosc; 2012 Jun; 75(6):1139-46.e2. PubMed ID: 22520270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant versus adjuvant chemoradiation for stage II-III esophageal squamous cell carcinoma: a single institution experience.
    Chen Y; Hao D; Wu X; Xing W; Yang Y; He C; Wang W; Liu J; Wang J
    Dis Esophagus; 2017 Jul; 30(7):1-7. PubMed ID: 28475725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EGFR Expression in Patients with Esophageal Squamous Cell Carcinoma and its Association with Pathologic Response to Preoperative Chemoradiotherapy: A Study in Northeastern Iran.
    Anvari K; Sima HR; Seilanian Toussi M; Anvari A; Shahidsales S; Memar B; Aledavoud SA; Forghani MN; Abdollahi A; Ghaffarzadegan K
    Arch Iran Med; 2017 Apr; 20(4):240-245. PubMed ID: 28412829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-center phase II trial of chemo-radiotherapy with 5-fluorouracil, leucovorin and oxaliplatin in locally advanced esophageal cancer.
    Chiarion-Sileni V; Innocente R; Cavina R; Ruol A; Corti L; Pigozzo J; Del Bianco P; Fumagalli U; Santoro A; Ancona E
    Cancer Chemother Pharmacol; 2009 May; 63(6):1111-9. PubMed ID: 18825381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant chemotherapy and external radiotherapy plus brachytherapy for locally advanced esophageal cancer: results of a retrospective multicenter study.
    Tessa M; Rotta P; Ragona R; Sola B; Grassini M; Nassisi D; Sciacero P; Airoldi M; Filippi A; Gianello L; De Angelis C; Ozzello F; Trotti AB; Ricardi U; Sannazzari GL
    Tumori; 2005; 91(5):406-14. PubMed ID: 16459637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II trial of preoperative chemoradiotherapy with oxaliplatin, cisplatin, and 5-FU in locally advanced esophageal and gastric cancer.
    Pera M; Gallego R; Montagut C; Martín-Richard M; Iglesias M; Conill C; Reig A; Balagué C; Pétriz L; Momblan D; Bellmunt J; Maurel J
    Ann Oncol; 2012 Mar; 23(3):664-670. PubMed ID: 21652581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of neoadjuvant therapy in the treatment of locally advanced squamous cell cancer of the cervical oesophagus].
    Papp A; Cseke L; Varga G; Pavlovics G; Potó L; Márton S; Farkas R; Bellyei S; Horváth OP
    Magy Seb; 2012 Oct; 65(5):340-7. PubMed ID: 23086818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Who profits from neoadjuvant radiochemotherapy for locally advanced esophageal carcinoma?
    Kersting S; Konopke R; Dittert D; Distler M; Rückert F; Gastmeier J; Baretton GB; Saeger HD
    J Gastroenterol Hepatol; 2009 May; 24(5):886-95. PubMed ID: 19655439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative low-dose weekly cisplatin and continuous infusion fluorouracil plus hyperfractionated radiotherapy in stage II-III esophageal carcinoma.
    Caro M; Font A; Comas S; Viciano M; Remon J; Céliz P; Robles J; Musulén E; Sendrós MJ; Mesalles E; Jiménez JA; Boix J; Arellano A; Fernández-Llamazares J
    Clin Transl Oncol; 2016 Nov; 18(11):1106-1113. PubMed ID: 26856597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative chemotherapy vs chemoradiotherapy for thoracic esophageal cancer: a prospective randomized clinical trial.
    Tachibana M; Yoshimura H; Kinugasa S; Shibakita M; Dhar DK; Ueda S; Fujii T; Nagasue N
    Eur J Surg Oncol; 2003 Sep; 29(7):580-7. PubMed ID: 12943623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I/II trial of preoperative oxaliplatin, docetaxel, and capecitabine with concurrent radiation therapy in localized carcinoma of the esophagus or gastroesophageal junction.
    Spigel DR; Greco FA; Meluch AA; Lane CM; Farley C; Gray JR; Clark BL; Burris HA; Hainsworth JD
    J Clin Oncol; 2010 May; 28(13):2213-9. PubMed ID: 20351330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation Therapy for Patients With Esophageal Cancer: The NRG Oncology RTOG 0436 Phase 3 Randomized Clinical Trial.
    Suntharalingam M; Winter K; Ilson D; Dicker AP; Kachnic L; Konski A; Chakravarthy AB; Anker CJ; Thakrar H; Horiba N; Dubey A; Greenberger JS; Raben A; Giguere J; Roof K; Videtic G; Pollock J; Safran H; Crane CH
    JAMA Oncol; 2017 Nov; 3(11):1520-1528. PubMed ID: 28687830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term survival based on pathologic response to neoadjuvant therapy in esophageal cancer.
    Tiesi G; Park W; Gunder M; Rubio G; Berger M; Ardalan B; Livingstone A; Franceschi D
    J Surg Res; 2017 Aug; 216():65-72. PubMed ID: 28807215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of hemoglobin levels on survival after radical treatment of esophageal carcinoma with radiotherapy.
    Valencia Julve J; Alonso Orduña V; Escó Barón R; López-Mata M; Méndez Villamón A
    Clin Transl Oncol; 2006 Jan; 8(1):22-30. PubMed ID: 16632436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term survival following induction chemoradiotherapy and esophagectomy for esophageal carcinoma.
    Lew JI; Gooding WE; Ribeiro U; Safatle-Ribeiro AV; Posner MC
    Arch Surg; 2001 Jul; 136(7):737-42; discussion 743. PubMed ID: 11448381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.